Th17 cells have stem cell-like features and promote long-term immunity

OncoImmunology

Volumn 1, Issue 4, 2012, Pages 516-519

  Wei, Shuang ^a   Zhao, Ende ^a   Kryczek, Ilona ^a,b,c   Zou, Weiping ^a,b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

Apoptosis; Bcl2; HIF; IL 17; Memory T cell; Notch; Stem cell; Survival; Th17 cell; Tumor immunity

Indexed keywords

GAMMA INTERFERON; PROTEIN BCL 2;

ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL FATE; CELL RENEWAL; CELL SURVIVAL; CELLULAR IMMUNITY; CYTOKINE RESPONSE; GENETIC ASSOCIATION; LYMPHOCYTE DIFFERENTIATION; MEMORY T LYMPHOCYTE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SURFACE PROPERTY; TH17 CELL; TUMOR MICROENVIRONMENT;

EID: 84872438964     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.19440     Document Type: Article

References (23)

1. Lanzavecchia A, Sallusto F. Progressive differentiation and selection of the fittest in the immune response. Nat Rev Immunol 2002; 2:982-7; http://dx.doi.org/10.1038/nri959
2. Fearon DT, Manders P, Wagner SD. Arrested differentiation, the self-renewing memory lymphocyte, and vaccination. Science 2001; 293:248-50; http://dx.doi.org/10.1126/science.1062589
3. Pagès F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005; 353:2654-66; http://dx.doi.org/10.1056/NEJMoa051424
4. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313: 1960-4; http://dx.doi.org/10.1126/science.1129139
5. Feuerer M, Beckhove P, Bai L, Solomayer EF, Bastert G, Diel IJ, et al. Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow. Nat Med 2001; 7:452-8; http://dx.doi.org/10.1038/86523
6. Feuerer M, Beckhove P, Garbi N, Mahnke Y, Limmer A, Hommel M, et al. Bone marrow as a priming site for T-cell responses to blood-borne antigen. Nat Med 2003; 9:1151-7; http://dx.doi.org/10.1038/nm914
7. Curiel TJ, Wei S, Dong H, Alvarez X, Cheng P, Mottram P, et al. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med 2003; 9:562-7; http://dx.doi.org/10.1038/nm863
8. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10:942-9; http://dx.doi.org/10.1038/nm1093
9. Kryczek I, Zou L, Rodriguez P, Zhu G, Wei S, Mottram P, et al. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med 2006; 203:871-81; http://dx.doi.org/10.1084/jem.20050930
10. Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S, et al. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 2009; 114:1141-9; http://dx.doi.org/10.1182/blood-2009-03-208249
11. Kryczek I, Bruce AT, Gudjonsson JE, Johnston A, Aphale A, Vatan L, et al. Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol 2008; 181:4733-41;
12. Kryczek I, Zhao E, Liu Y, Wang Y, Vatan L, Szeliga W, et al. Human TH17 cells are long-lived effector memory cells. Sci Transl Med 2011; 3: 104ra100; http://dx.doi.org/10.1126/scitranslmed.3002949
13. Muranski P, Borman ZA, Kerkar SP, Klebanoff CA, Ji Y, Sanchez-Perez L, et al. Th17 Cells Are Long Lived and Retain a Stem Cell-like Molecular Signature. Immunity 2011; 35:972-85; http://dx.doi.org/10.1016/j.immuni.2011.09.019
14. Zou W, Restifo NPT. T(H)17 cells in tumour immunity and immunotherapy. Nat Rev Immunol 2010; 10:248-56; http://dx.doi.org/10.1038/nri2742
15. Pepper M, Linehan JL, Pagán AJ, Zell T, Dileepan T, Cleary PP, et al. Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat Immunol 2010; 11:83-9; http://dx.doi.org/10.1038/ni.1826
16. Chang JT, Palanivel VR, Kinjyo I, Schambach F, Intlekofer AM, Banerjee A, et al. Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science 2007; 315:1687-91; http://dx.doi.org/10.1126/science.1139393
17. Turtle CJ, Swanson HM, Fujii N, Estey EH, Riddell SR. A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy. Immunity 2009; 31:834-44; http://dx.doi.org/10.1016/j.immuni.2009.09.015
18. Zhang Y, Joe G, Hexner E, Zhu J, Emerson SG. Hostreactive CD8+ memory stem cells in graft-versus-host disease. Nat Med 2005; 11:1299-305; http://dx.doi.org/10.1038/nm1326
19. Gattinoni L, Zhong XS, Palmer DC, Ji Y, Hinrichs CS, Yu Z, et al. Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells. Nat Med 2009; 15:808-13; http://dx.doi.org/10.1038/nm.1982
20. Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, Quigley MF, et al. A human memory T cell subset with stem cell-like properties. Nat Med 2011; 17:1290-7; http://dx.doi.org/10.1038/nm.2446
21. Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, Zheng Y, et al. Control of T(H)17/T(reg) balance by hypoxiainducible factor 1. Cell 2011; 146:772-84; http://dx.doi.org/10.1016/j.cell.2011.07.033
22. Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: moving beyond current vaccines. Nat Med 2004; 10:909-15; http://dx.doi.org/10.1038/nm1100
23. Gattinoni L, Powell DJ, Jr., Rosenberg SA, Restifo NP. Adoptive immunotherapy for cancer: building on success. Nat Rev Immunol 2006; 6:383-93; http://dx.doi.org/10.1038/nri1842